OR WAIT null SECS
© 2021 MJH Life Sciences and Pharmaceutical Executive. All rights reserved.
© 2021 MJH Life Sciences™ and Pharmaceutical Executive. All rights reserved.
July 13, 2021
Understanding of recent legal developments can help companies avoid infringement.
May 13, 2021
The eight key areas biopharma manufacturers must stay on top of when planning and executing alliance agreements with prospective digital health partners.
April 08, 2021
In an unpredictable world, international life sciences collaborations can lead to misunderstandings and enforcement challenges, making an effective dispute resolution mechanism an essential risk management tool.
March 23, 2021
Assessing the implications for the pharma industry of the America Rescue Plan Act of 2021, which provides nearly two trillion dollars in funding for various government programs, including many related to public health.
March 22, 2021
Mitigating potential risk for stakeholders in light of latest Sunshine Act developments.
March 11, 2021
Treat patents as strategic business assets and build an IP portfolio.
Disputes over mRNA-related patents are poised to persist.
Fighting the pandemic with joint projects and IP sharing.
March 09, 2021
Exploring practical points to further understand and strengthen quality culture.
February 19, 2021
Cybersecurity vulnerabilities embedded in AI and machine learning pose significant litigation risks as life sciences companies move to digital technologies.